Predictmedix AI Inc.
Predictmedix AI Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry. Predictmedix is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease.
Predictmedix AI Inc. (PMED)
le 14 juillet/July 2023
Predictmedix Inc. has announced a name change to Predictmedix AI Inc.
Shares will begin trading under the new name and with a new CUSIP number on July 17, 2023.